UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review

Journal of oncology pharmacy practice, 2021-06, Vol.27 (4), p.990-995

2021

Volltextzugriff (PDF)

Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use

Journal of oncology pharmacy practice, 2022-10, Vol.28 (7), p.1654-1658

2022

Volltextzugriff (PDF)

Rare Oral Presentation of a Mycophenolate Mofetil-Related Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder (MMF-OIA-LPD) Lesion: A Case Report and Literature Review

Journal of oral and maxillofacial surgery, 2021-02, Vol.79 (2), p.398-403

2021

Volltextzugriff (PDF)

Anti-PF4 ELISA-Negative, SRA-Positive Heparin-Induced Thrombocytopenia

Hematology reports, 2024-05, Vol.16 (2), p.295-298

2024

Volltextzugriff (PDF)

Three Cases of Lenalidomide Therapy for Multiple Myeloma and Subsequent Development of Secondary B-ALL

Journal of oncology pharmacy practice, 2022-07, Vol.28 (5), p.1214-1217

2022

Volltextzugriff (PDF)

Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis

Breast cancer (Tokyo, Japan), 2022-11, Vol.29 (6), p.1022-1031

2022

Volltextzugriff (PDF)

Management of congenital dysfibrinogenemia in pregnancy: A challenging patient case

Research and practice in thrombosis and haemostasis, 2021-12, Vol.5 (8), p.e12619-n/a, Article e12619

2021

Volltextzugriff (PDF)

Intensity of Cancer Care Near the End of Life at a Tertiary Care Cancer Center in Jordan

Journal of pain and symptom management, 2019-06, Vol.57 (6), p.1106-1113

2019

Volltextzugriff (PDF)

747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A843-A843

2023

Volltextzugriff (PDF)

778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A875-A875

2023

Volltextzugriff (PDF)

Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York

Journal of community hospital internal medicine perspectives, 2016, Vol.6 (4), p.32522-3

2016

Volltextzugriff (PDF)

Non-Myeloablative Lymphodepleting Conditioning in Patients Undergoing Tumor Infiltrating Lymphocytes (TILs) Therapy; Past, Present, and Future

Blood, 2022-11, Vol.140 (Supplement 1), p.12714-12715

2022

Volltextzugriff (PDF)

Does low-grade follicular lymphoma with high proliferation index require a different treatment strategy? A single center experience

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e19537-e19537

2023

Volltextzugriff (PDF)

A Case of Primary Dural Lymphoma Treated with Bendamustine and Rituxan

Blood, 2022-11, Vol.140 (Supplement 1), p.11995-11996

2022

Volltextzugriff (PDF)

A Challenging Case of Atypical Hemolytic Uremic Syndrome in a Young African American Patient

Blood, 2021-11, Vol.138 (Supplement 1), p.4225-4225

2021

Volltextzugriff (PDF)

An internal review of rates of palliative medicine referral for patients with advanced pancreatic cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16245-e16245

2021

Volltextzugriff (PDF)

Su365 THE ROLE OF BETA BLOCKERS IN PRIMARY PROPHYLAXIS OF GASTRIC VARICEAL BLEEDING: A SYSTEMATIC REVIEW

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-865-S-865

2021

Volltextzugriff (PDF)

Effect of obesity on resection margins in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemotherapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16229-e16229

2022

Volltextzugriff (PDF)

A national inpatient sample analysis for CAR-T cell therapy administration

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e19501-e19501

2022

Volltextzugriff (PDF)

SARS CoV-2 vaccine seroconversion and infection rates in patients on active cancer-directed therapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18683-e18683

2022

Volltextzugriff (PDF)

Inpatient outcomes of blinatumomab use: A national inpatient sample analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e19021-e19021

2022

Volltextzugriff (PDF)

The rate of venous thromboembolism in patients with non-small cell lung cancer treated with chemotherapy or check point inhibitors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21053-e21053

2022

Volltextzugriff (PDF)

Impact of education and electronic decision support tool on the practice of heparin-induced thrombocytopenia testing: An experience of a teaching community hospital

Thrombosis research, 2018-09, Vol.169, p.73-75

2018

Volltextzugriff (PDF)

Venetoclax-induced vitiligo in a patient with chronic lymphocytic leukemia

Anti-cancer drugs, 2022-11, Vol.33 (10), p.1167

2022

Volltextzugriff (PDF)

Bispecific T-Cell Engager Antibodies in Multiple Myeloma- a Systematic Review of Phase 1 Clinical Trials

Blood, 2021-11, Vol.138 (Supplement 1), p.4775-4775

2021

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(82)
Berichte
(5)

Sprache

Englisch
(87)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review

Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use

Rare Oral Presentation of a Mycophenolate Mofetil-Related Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder (MMF-OIA-LPD) Lesion: A Case Report and Literature Review

Anti-PF4 ELISA-Negative, SRA-Positive Heparin-Induced Thrombocytopenia

Three Cases of Lenalidomide Therapy for Multiple Myeloma and Subsequent Development of Secondary B-ALL

Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis

Management of congenital dysfibrinogenemia in pregnancy: A challenging patient case

Intensity of Cancer Care Near the End of Life at a Tertiary Care Cancer Center in Jordan

747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors

778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma

Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York

Non-Myeloablative Lymphodepleting Conditioning in Patients Undergoing Tumor Infiltrating Lymphocytes (TILs) Therapy; Past, Present, and Future

Does low-grade follicular lymphoma with high proliferation index require a different treatment strategy? A single center experience

A Case of Primary Dural Lymphoma Treated with Bendamustine and Rituxan

A Challenging Case of Atypical Hemolytic Uremic Syndrome in a Young African American Patient

An internal review of rates of palliative medicine referral for patients with advanced pancreatic cancer

Su365 THE ROLE OF BETA BLOCKERS IN PRIMARY PROPHYLAXIS OF GASTRIC VARICEAL BLEEDING: A SYSTEMATIC REVIEW

Effect of obesity on resection margins in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemotherapy

A national inpatient sample analysis for CAR-T cell therapy administration

SARS CoV-2 vaccine seroconversion and infection rates in patients on active cancer-directed therapy

Inpatient outcomes of blinatumomab use: A national inpatient sample analysis

The rate of venous thromboembolism in patients with non-small cell lung cancer treated with chemotherapy or check point inhibitors

Impact of education and electronic decision support tool on the practice of heparin-induced thrombocytopenia testing: An experience of a teaching community hospital

Venetoclax-induced vitiligo in a patient with chronic lymphocytic leukemia

Bispecific T-Cell Engager Antibodies in Multiple Myeloma- a Systematic Review of Phase 1 Clinical Trials

Suchergebnisse filtern